NOV 03, 2021 10:00 AM PDT

Streamline your path from immunodiagnostic development to commercialization

Speaker

Abstract
Date:  November 3, 2021
Time: 10:00am (PDT),  1:00pm (EDT)
 
Developing an immunodiagnostic assay is a partnership from initial development through launch. Thermo Fisher Scientific’s Global OEM & Licensing (GOaL) team supports our partners’ development and commercialization of immunodiagnostic assays using a wide array of products and technologies. Our team of subject matter experts use their many years of experience to help guide your reagent selections and confirm that the commercial rights and necessary licenses are in place for the components being sourced. Working together with the GOaL team can help to ensure consistent performance and security of supply of important reagents. Post-launch, we work with our partners to maintain performance through features such as lot-to-lot consistency and change notification. This webinar will provide immunodiagnostics developers with the insight required to accelerate commercialization, as well as an understanding of the products, technologies, and capabilities at our various Centers of Excellence.
 
 
Learning Objectives:
 
  • Discuss the selection of the optimal reagents to achieve your assay development goals
  • Discuss how to obtain the necessary rights for using reagents in commercial applications
  • Explore maximizing product performance, reproducibility, and security of supply
  • Discuss the importance of providing accurate forecasts and plans to your suppliers to ensure reliable, consistent, product availability
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
DEC 07, 2021 9:00 AM PST
C.E. CREDITS
DEC 07, 2021 9:00 AM PST
Date: December 7, 2021 Time: 9:00am (PST), 12:00pm (EST) The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than...
Loading Comments...
Show Resources